Opinion

Video

Top 10 Urology Times videos of 2024

As the year comes to a close, we revisit some of this year’s top video content from Urology Times.

The Urology Times team conducted dozens of video interviews in 2024, comprising a variety of topics, ranging from erectile dysfunction to urinary tract infection. Here are the top-performing Urology Times videos of 2024.

Dr. Dubin on trends in erectile dysfunction medication usage

Blur image of hospital | Image Credit: © whyframeshot - stock.adobe.com

Justin M. Dubin, MD, shares key findings from the study, “Beyond the prescription: trends and challenges in erectile dysfunction medications among young adult men,” for which he served as the senior author. Watch the video here

Olivia Paulsen on the association between BPH and erectile dysfunction

Olivia Paulsen gives an overview of the study “Benign Prostatic Enlargement Is Associated With Erectile Dysfunction in United States,” which she presented at the 25th Fall Scientific Meeting of the Sexual Medicine Society of North in Scottsdale, Arizona. Watch the video here

Dr. Bernie on testosterone therapy for men on active surveillance

Helen L. Bernie, DO, MPH, highlights the lack of long-term data on testosterone therapy for men on active surveillance for prostate cancer. Watch the video here

Urologist discusses Aquablation, rise in large prostates seen in his practice

Joseph Song, MD, discusses Aquablation and shares an observation regarding an increase in large prostates. Watch the video here

Dr. Hougen on adding a coefficient for Black race to the 4Kscore

Helen Y. Hougen, MD, shares the background and findings from the study, “Adding a Coefficient for Race to the 4Kscore Improves Calibration for Black Men.” Watch the video here

Dr. Dubin on the direct-to-consumer market for erectile dysfunction medications

Justin M. Dubin, MD, discusses the rationale for the study, “Beyond the prescription: trends and challenges in erectile dysfunction medications among young adult men.” Watch the video here

Dr. Soon-Shiong discusses the FDA approval of N-803 in NMIBC

In April 2024, the FDA approved N-803 (Anktiva, nogapendekin alfa inbakicept-pmln), a first-in-class IL-15 receptor agonist immunotherapy for use in combination with BCG for the treatment of patients with BCG-unresponsive non–muscle-invasive bladder cancer (NMIBC) with carcinoma in situ with or without papillary tumors. In this interview, Patrick Soon-Shiong, MD, discusses the significance of the FDA approval for immunotherapy in NMIBC. Watch the video here

Steven A. Kaplan, MD, shares initial data on sildenafil oral spray vs tablets

Steven A. Kaplan, MD, shares findings from a phase 1 study of ASP-001, an investigational oral formulation of sildenafil for patients with erectile dysfunction. Watch the video here

Dr. Meddings on catheterizing for urinary retention

Jennifer Ann Meddings, MD, MSc, describes the background and notable findings from the JAMA Network Open paper “Urinary Retention Evaluation and Catheterization Algorithm for Adult Inpatients.” Watch the video here

Dr. Varda on challenges in the diagnosis of urinary tract infection

Briony K. Varda, MD, MPH, discusses the key take-home messages from the study, “Antibiotic Overtreatment of Presumed Urinary Tract Infection Among Children with Spina Bifida,” for which she served as the lead author. Watch the video here

Related Videos
Wayne Kuang, MD, answers a question during a Zoom video interview
3d rendered illustration - bladder | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
Wayne Kuang, MD, answers a question during a Zoom video interview
© 2024 MJH Life Sciences

All rights reserved.